RxDoctor Payments Data

Margie Montgomery

Family · Macon, GANPI 1669961272

Payments from drug & device makers

$4,142in general payments, 2019–2025

Across 253 payments — averaging $16.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$661
  • Novo Nordisk$457
  • Lilly USA, LLC$332
  • Amgen$264
  • Abbott$258
  • Boehringer Ingelheim$211
  • plus $2K from 29 others

What the payments were for

  • Food & beverage$4,09099%
  • Education$521%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,142 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide22$27,545
JardianceEmpagliflozin13$20,466
Rosuvastatin Calcium106$2,039
SynthroidLevothyroxine Sodium11$1,506
Bupropion XlBupropion Hcl13$766
Ibandronate Sodium21$519
Levothyroxine Sodium69$474
Ezetimibe19$459
Escitalopram Oxalate30$412
Atorvastatin Calcium61$411
Lisinopril19$404
Losartan Potassium34$400
Metformin Hcl ErMetformin Hcl41$372
Esomeprazole Magnesium12$370
Buspirone Hcl30$340

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$457$27,54522 claims
Boehringer IngelheimJardiance$211$20,46613 claims
AbbVieSynthroid$661$1,50611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,258 family providers in Georgia.

Other family in Macon

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →